NCT02294461 2025-10-24An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer ParticipantsAstellas Pharma IncPhase 3 Completed395 enrolled 25 charts